Advance of Research on the Immunotherapy Targeting B Cell Maration Antigen for Multiple Myeloma--Review / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 1701-1705, 2019.
Article
в Zh
| WPRIM
| ID: wpr-775662
Ответственная библиотека:
WPRO
ABSTRACT
Abstract B cell maturation antigen (BCMA) is an ideal target for precise treatment due to its highly selective expression on malignant myeloma cells. This review summarizes briefly the advances in the latest research progress on biological activity of BCMA, its significance as a biomarker and immunotherapy direcited against BCMA, such as bispecific antibodies, antibody drug conjugates, chimeric antigen receptor T cell therapy against mature B cell antigens.
Полный текст:
1
База данных:
WPRIM
Основная тема:
Therapeutics
/
B-Lymphocytes
/
T-Lymphocytes
/
Antigens, Differentiation, B-Lymphocyte
/
B-Cell Maturation Antigen
/
Immunotherapy
/
Multiple Myeloma
Пределы темы:
Humans
Язык:
Zh
Журнал:
Journal of Experimental Hematology
Год:
2019
Тип:
Article